US: IDE (investigational device exemption) does not necessarily equal national coverage
This article was originally published in Clinica
Executive Summary
An FDA investigational device exemption for a product does not automatically guarantee nationwide coverage for the product, a local Medicare carrier warned last week. Saty Satya-Murti, Medicare medical director for Blue Cross and Blue shield of Kansas, says there are times when local carriers choose not to cover such investigational products.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.